These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29084447)

  • 1. Proteomic Profiling of a Primary CD4
    Saha JM; Liu H; Hu PW; Nikolai BC; Wu H; Miao H; Rice AP
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):103-110. PubMed ID: 29084447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.
    Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR
    Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
    Jung U; Takahashi M; Rossi JJ; Burnett JC
    Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
    Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
    Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
    Mann JFS; Pankrac J; Klein K; McKay PF; King DFL; Gibson R; Wijewardhana CN; Pawa R; Meyerowitz J; Gao Y; Canaday DH; Avino M; Poon AFY; Foster C; Fidler S; Shattock RJ; Arts EJ
    EBioMedicine; 2020 Sep; 59():102853. PubMed ID: 32654992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latency.
    Kim Y; Cameron PU; Lewin SR; Anderson JL
    J Int AIDS Soc; 2019 Dec; 22(12):e25425. PubMed ID: 31855322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
    Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
    J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch.
    Venkatachari NJ; Zerbato JM; Jain S; Mancini AE; Chattopadhyay A; Sluis-Cremer N; Bar-Joseph Z; Ayyavoo V
    Retrovirology; 2015 Oct; 12():85. PubMed ID: 26438393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oocyte activation and latent HIV-1 reactivation: AMPK as a common mechanism of action linking the beginnings of life and the potential eradication of HIV-1.
    Finley J
    Med Hypotheses; 2016 Aug; 93():34-47. PubMed ID: 27372854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation.
    Vemula SV; Maxwell JW; Nefedov A; Wan BL; Steve J; Newhard W; Sanchez RI; Tellers D; Barnard RJ; Blair W; Hazuda D; Webber AL; Howell BJ
    Antiviral Res; 2017 Mar; 139():161-170. PubMed ID: 27889530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.
    Röling M; Mollapour Sisakht M; Ne E; Moulos P; Crespo R; Stoszko M; De Crignis E; Bodmer H; Kan TW; Akbarzadeh M; Harokopos V; Hatzis P; Palstra RJ; Mahmoudi T
    mBio; 2021 Dec; 12(6):e0298021. PubMed ID: 34872356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.
    Carlin E; Greer B; Lowman K; Duverger A; Wagner F; Moylan D; Dalecki A; Samuel S; Perez M; Sabbaj S; Kutsch O
    PLoS Pathog; 2021 Jan; 17(1):e1008748. PubMed ID: 33465149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells.
    Shan L; Xing S; Yang HC; Zhang H; Margolick JB; Siliciano RF
    J Antimicrob Chemother; 2014 Jan; 69(1):28-33. PubMed ID: 23999005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
    White CH; Moesker B; Beliakova-Bethell N; Martins LJ; Spina CA; Margolis DM; Richman DD; Planelles V; Bosque A; Woelk CH
    PLoS Pathog; 2016 Nov; 12(11):e1006026. PubMed ID: 27898737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.